KN-015

重组人促卵泡激素Fc融合蛋白（康宁杰瑞）

Report date: 2026/05/20 20:02:01

Base Information

Drug NameKN-015
Drug Alias NameKN-015
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Alphamab Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAlphamab Jilin Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, Female
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A